Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2012, Article ID 473572, 14 pages
http://dx.doi.org/10.1155/2012/473572
Research Article

Assessing the Effects of Estrogen on the Dynamics of Breast Cancer

Modelling Biomedical Systems Research Group, Department of Applied Mathematics, National University of Science and Technology, P.O. Box AC 939, Ascot, Bulawayo, Zimbabwe

Received 8 August 2012; Revised 2 November 2012; Accepted 12 November 2012

Academic Editor: Scott Penfold

Copyright © 2012 Chipo Mufudza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts and Figures 2011.
  2. International Agency for Research on Cancer, Cancer Survival in Africa, Asia, the Caribbean and Central America, 2011, Edited by R. Sankaranarayanan, R. Swaminathan, K. Jayant, and H. Brenner.
  3. American Cancer Society, Cancer Facts and Figures 2012.
  4. M. Tokunaga, C. E. Land, S. Tokuoka, I. Nishimori, M. Soda, and S. Akiba, “Incidence of female breast cancer among atomic bomb survivors, 1950–1985,” Radiation Research, vol. 138, no. 2, pp. 209–223, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. A. B. Miller, G. R. Howe, G. J. Sherman et al., “Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis,” The New England Journal of Medicine, vol. 321, no. 19, pp. 1285–1289, 1989. View at Google Scholar · View at Scopus
  6. A. Lanfranchi and J. Brind, Breast Cancer: Risks and Prevention, Breast Cancer Prevention Institute, 4th edition, 2007.
  7. D. Thompson, D. Easton, and The Breast cancer linkage consortium, “Cancer incidencein BCR1-mutation carriers,” Journal of the National Cancer Institute, vol. 94, no. 18, pp. 1358–1365, 2002. View at Publisher · View at Google Scholar
  8. N. Avis, S. Crawford, and J. Manuel, “Quality of life among younger women with breast cancer,” Journal of Clinical Oncology, vol. 23, no. 15, pp. 3322–3330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. National Cancer Institute, “Breast Cancer Risk Increased in BRCA2 Carriers in Iceland,” NCI Cancer Bulletin, vol. 3, no. 4, 2006. View at Google Scholar
  10. J. D. Yager and N. E. Davidson, “Estrogen carcinogenesis in breast cancer,” The New England Journal of Medicine, vol. 354, no. 3, pp. 270–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Villasana, A delay differential equation model for tumor growth [Ph.D. dissertation], Claremont University, 2001.
  12. M. Villasana and A. Radunskaya, “A delay differential equation model for tumor growth,” Journal of Mathematical Biology, vol. 47, no. 3, pp. 270–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. L. G. De Pillis and A. Radunskaya, “A mathematical tumor model with immune resistance and drug therapy. An optimal control approach,” Journal of Theoretical Medicine, vol. 3, no. 2, pp. 79–100, 2001. View at Google Scholar · View at Scopus
  14. G. Bani, M. Biggazi, and T. Sacchi, “Relaxin as a mammotrophic hormone,” Experimental and Clinical Endocrinology, vol. 10, pp. 143–150, 1991. View at Google Scholar
  15. R. C. Mercado-Simmen, G. D. Bryant-Greenwood, and F. C. Green-wood, “Relaxin receptor in the rat myometrium: regulation by estrogen and relaxin,” Endocrinology, vol. 110, no. 1, pp. 220–226, 1982. View at Google Scholar · View at Scopus
  16. G. A. Colditz, “Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer,” Journal of the National Cancer Institute, vol. 90, no. 11, pp. 814–823, 1998. View at Google Scholar · View at Scopus
  17. C. Kahlenborn, F. Modugno, D. M. Potter, and W. B. Severs, “Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis,” Mayo Clinic Proceedings, vol. 81, no. 10, pp. 1290–1302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Crooke, C. Justenhoven, H. Brauch et al., “Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 7, pp. 1502–1515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Collaborative Group on Hormonal Factors in Breast Cancer, “Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer,” The Lancet, vol. 350, no. 9084, pp. 1047–1059, 1997. View at Google Scholar
  20. T. Sacchi, “Relaxin influences the growth of MCF-7 breast cancer cells,” Cancer, vol. 70, no. 3, pp. 639–643, 1992. View at Google Scholar
  21. S. Yaghoubi, J. Barlow, and P. H. Kass, Breast cancer and metals: a literature review, zero breast cancer [Ph.D. thesis], University of Califonia, Davis, Calif, USA, 2007.
  22. R. Yafia, “Dynamics analysis and limit cycle in a delayed model for tumor growth with quiescence,” Nonlinear Analysis: Modelling and Control, vol. 11, no. 1, pp. 95–110, 2006. View at Google Scholar
  23. L. E. Green, T. A. Dinh, and R. A. Smith, “An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk,” Computational and Mathematical Methods in Medicine, vol. 2012, Article ID 792375, 8 pages, 2012. View at Publisher · View at Google Scholar
  24. L. G. DePillis and A. Radunskaya, “A mathematical model of immune response to tumor invasion, Computational fluid and solid mechanics,” in Proceedings of the 2nd MIT Conference on Computational Fluid and Solid Mechanics, pp. 1661–1668, June 2003.
  25. G. Newbury, A numerical study of a delay differential equation model for breast cancer [M.S. thesis], Faculty of the Virginia Polytechnic Institute and State University, 2007.
  26. H. A. Mattsson and K. U. Nyquist, A mathematical investigation of breast cancer and tumor growth. Statistical analysis and stochastic modelling2009 [M.S. thesis], Department of Mathematical Statistics, Chalmers University of Technology, University of Gothenburg, Gothenburg, Sweden, 2009.
  27. V. A. Kuznetsov, I. A. Makalkin, M. A. Taylor, and A. S. Perelson, “Nonlinear dynamics of immunogenic tumors. Parameter estimation and global bifurcation analysis,” Bulletin of Mathematical Biology, vol. 56, no. 2, pp. 295–321, 1994. View at Google Scholar · View at Scopus
  28. A. C. Burton, “Rate of growth of solid tumours as a problem of diffusion,” Growth, Development and Aging, vol. 30, no. 2, pp. 157–176, 1966. View at Google Scholar · View at Scopus
  29. J. A. Adam, “A simplified mathematical model of tumor growth,” Mathematical Biosciences, vol. 81, no. 2, pp. 229–244, 1986. View at Google Scholar · View at Scopus
  30. J. J. Casciari, S. V. Sotirchos, and R. M. Sutherland, “Mathematical modelling of microenvironment and growth in EMT6/Ro multicellular tumour spheroids,” Cell Proliferation, vol. 25, no. 1, pp. 1–22, 1992. View at Google Scholar · View at Scopus
  31. M. H. Gail, L. A. Brinton, D. P. Byar et al., “Projecting individualized probabilities of developing breast cancer for white females who are being examined annually,” Journal of the National Cancer Institute, vol. 81, no. 24, pp. 1879–1886, 1989. View at Google Scholar · View at Scopus
  32. J. D. Boice and R. W. Miller, “Childhood and adult cancer after intrauterine exposure to ionizing radiation,” Teratology, vol. 59, no. 4, pp. 227–233, 1999. View at Google Scholar
  33. M. Donovan, C. M. Tiwary, D. Axelrod et al., “Personal care products that contain estrogens or xeno-estrogens may increase breast cancer risk,” Medical Hypotheses, vol. 68, no. 4, pp. 756–766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Zeigler, T. Kim, and H. Praehofer, Theory of Modelling and Simulation. Integrating Discrete Event and Continuous Complex Dynamic System, Academic press, 2000.
  35. R. Goldstein and G. Wainer, “Modelling tumor-immune systems with Cell-DEVS,” in Proceedings of the European Conference on Modelling and Simulation (ECMS '08), Nicosia, Cyprus, June 2008.
  36. Y. L. Chia, P. Salzman, S. K. Plevritis, and P. W. Glynn, “Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration,” Statistical Methods in Medical Research, vol. 13, no. 6, pp. 507–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. G. G. Steel, Growth Kinetics of Tumours, Clarendon Press, 1977.
  38. R. K. Sachs, L. R. Hlatky, and P. Hahnfeldt, “Simple ODE models of tumor growth and anti-angiogenic or radiation treatment,” Mathematical and Computer Modelling, vol. 33, no. 12-13, pp. 1297–1305, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. R. A. Gatenby, “The potential role of transformation-induced metabolic changes in tumor-host interaction,” Cancer Research, vol. 55, no. 18, pp. 4151–4156, 1995. View at Google Scholar · View at Scopus
  40. A. A. Neves and K. M. Brindle, “Assessing responses to cancer therapy using molecular imaging,” Biochimica et Biophysica Acta, vol. 1766, no. 2, pp. 242–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. R. P. Jimenez and E. O. Hernandez, “Tumor host dynamics under radiotherapy,” Chaos, Solitons & Fractals, vol. 44, no. 9, pp. 685–692, 2011. View at Publisher · View at Google Scholar
  42. C. Castilo-Chavez, Z. Feng, and W. Haung, “On the computation of R0 and its role on global stability,” in Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction, C. Castillo-Chavez, S. Blower, P. van den Driessche et al., Eds., vol. 125 of IMA, pp. 229–250, 2002. View at Google Scholar
  43. E. M. Curran, B. M. Judy, N. A. Duru et al., “Estrogenic regulation of host immunity against an estrogen receptor—negative human breast cancer,” Clinical Cancer Research, vol. 12, no. 19, pp. 5641–5647, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Paruthiyil, H. Parmar, V. Kerekatte, G. R. Cunha, G. L. Firestone, and D. C. Leitmant, “Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest,” Cancer Research, vol. 64, no. 1, pp. 423–428, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Heldring, A. Pike, S. Andersson et al., “Estrogen receptors: how do they signal and what are their targets,” Physiological Reviews, vol. 87, no. 3, pp. 905–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Roggia, Y. Gao, S. Cenci et al., “Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 24, pp. 13960–13965, 2001. View at Publisher · View at Google Scholar · View at Scopus